PM
Desconocido
PIONEER: Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope
PINSENT MASONS LLP
participó en un
H2020:
H2020-JTI-IMI2-2016-10-two-stage
Prostate Cancer (PCa) is the second leading cause of cancer, among men in Europe. There are currently major unmet needs in this field, such...
2018-06-14 - 2023-10-31 | Financiado
2018-06-14 - 2023-10-31 | Financiado
GUIDENANO: Assessment and mitigation of nano enabled product risks on human and environmental health Developme...
PINSENT MASONS LLP
participó en un
FP7:
The main objective of GUIDEnano is to develop innovative methodologies to evaluate and manage human and environmental health risks of nano-e...
Financiado
Financiado
* No se disponen de datos de la empresa actual.